In recent years GLP-1 medications have surged in popularity, becoming a cornerstone in the management of certain chronic conditions, particularly Type 2 diabetes and obesity. The clinical benefits of these drugs are clear, but they come with a high price tag, raising important questions about cost management and long-term sustainability.

During this webinar we’ll explore GLP-1 medications in depth, providing you with the knowledge you need to make informed decisions about the best ways to incorporate these drugs into your benefits plan. Together we’ll discuss:

  • How GLP-1s work, including the scientific principles behind their efficacy
  • Practical cost-management strategies to offer these popular medications while maintaining financial health
  • Risk assessment and mitigation, providing you with the knowledge to help members safely navigate this rapidly expanding market

Panelists

Stanley Crittenden, M.D., FASN photo
Stanley Crittenden, M.D., FASN
Chief Medical Officer
Quantum Health
Janice Rosenthal RN photo
Janice Rosenthal RN
Clinical Consultant
Marsh McLennan Agency
Jordan Counts photo
Jordan Counts
Director, Pharmacy Services
Quantum Health

More like this

woman meditating with headphones on
Webinar

Digital Mental Health Benefits: Beyond Access, Toward Impact

Providing access to mental health resources isn’t enough. To drive sustainable outcomes, employers need to guide employees toward the right support at the right time — and help them use those resources effectively. 

Learn more
Quantum Health and Progyny logos
Webinar

Beyond Fertility: Supporting Women's Health at Every Stage

Women’s and family health needs are evolving, and employers must rethink benefits strategies to provide inclusive, comprehensive support. Join industry experts for a conversation on creating equitable benefits that go beyond fertility treatment to improve access, outcomes and cost efficiency.

Learn more
Vida and Quantum Health logo
Webinar

Managing GLP-1 Costs Without Compromising Outcomes

GLP-1 medications continue to surge in popularity, offering effective solutions for weight management, Type 2 diabetes, and other emerging indications. While these drugs show significant clinical benefits, their skyrocketing costs present a major challenge for self-insured employers. Current solutions fall short at addressing the core issue: ensuring members have access to these medications when appropriate while supporting long-term health and sustainable cost management.

Learn more